Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$13.35−0.37 (-2.70%)
Close on Nov 12, 2026Market cap $2.01BP/E –Yield 3.84%
Chemours total assets
Total assets on the balance sheet at the end of each period.
Chemours's total assets was $7.29B at Sep 30, 2026. For fiscal 2025 it was $7.38B, down 1.7% from the year before. Over ten years it grew 1.6% a year on average. The highest annual figure on record is $8.24B in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.38B | -1.7% |
| FY2024 | Dec 31, 2024 | $7.51B | -8.9% |
| FY2023 | Dec 31, 2023 | $8.24B | +7.9% |
| FY2022 | Dec 31, 2022 | $7.64B | +1.2% |
| FY2021 | Dec 31, 2021 | $7.55B | +6.6% |
| FY2020 | Dec 31, 2020 | $7.08B | -2.4% |
| FY2019 | Dec 31, 2019 | $7.26B | -1.4% |
| FY2018 | Dec 31, 2018 | $7.36B | +0.9% |
| FY2017 | Dec 31, 2017 | $7.29B | +20.3% |
| FY2016 | Dec 31, 2016 | $6.06B | -3.8% |
| FY2015 | Dec 31, 2015 | $6.30B | +5.7% |
| FY2014 | Dec 31, 2014 | $5.96B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.29B | -3.4% |
| Q2 FY2026 | Jun 30, 2026 | $7.15B | -4.2% |
| Q1 FY2026 | Mar 31, 2026 | $7.27B | -1.5% |
| Q4 FY2025 | Dec 31, 2025 | $7.38B | -1.7% |
| Q3 FY2025 | Sep 30, 2025 | $7.55B | +1.2% |
| Q2 FY2025 | Jun 30, 2025 | $7.46B | +3.0% |
| Q1 FY2025 | Mar 31, 2025 | $7.38B | -7.6% |
| Q4 FY2024 | Dec 31, 2024 | $7.51B | -8.9% |
| Q3 FY2024 | Sep 30, 2024 | $7.46B | -6.2% |
| Q2 FY2024 | Jun 30, 2024 | $7.25B | -5.4% |
| Q1 FY2024 | Mar 31, 2024 | $7.98B | +4.7% |
| Q4 FY2023 | Dec 31, 2023 | $8.24B | +7.9% |
| Q3 FY2023 | Sep 30, 2023 | $7.95B | +2.6% |
| Q2 FY2023 | Jun 30, 2023 | $7.66B | -0.9% |
| Q1 FY2023 | Mar 31, 2023 | $7.62B | +1.3% |
| Q4 FY2022 | Dec 31, 2022 | $7.64B | +1.2% |
| Q3 FY2022 | Sep 30, 2022 | $7.75B | +2.9% |
| Q2 FY2022 | Jun 30, 2022 | $7.73B | +3.4% |
| Q1 FY2022 | Mar 31, 2022 | $7.52B | +4.9% |
| Q4 FY2021 | Dec 31, 2021 | $7.55B | +6.6% |
| Q3 FY2021 | Sep 30, 2021 | $7.53B | +8.4% |
| Q2 FY2021 | Jun 30, 2021 | $7.48B | +6.3% |
| Q1 FY2021 | Mar 31, 2021 | $7.17B | +3.2% |
| Q4 FY2020 | Dec 31, 2020 | $7.08B | -2.4% |
| Q3 FY2020 | Sep 30, 2020 | $6.95B | -6.8% |
| Q2 FY2020 | Jun 30, 2020 | $7.03B | -5.4% |
| Q1 FY2020 | Mar 31, 2020 | $6.95B | -5.1% |
| Q4 FY2019 | Dec 31, 2019 | $7.26B | -1.4% |
| Q3 FY2019 | Sep 30, 2019 | $7.46B | -0.7% |
| Q2 FY2019 | Jun 30, 2019 | $7.43B | +1.3% |
| Q1 FY2019 | Mar 31, 2019 | $7.33B | -2.1% |
| Q4 FY2018 | Dec 31, 2018 | $7.36B | +0.9% |
| Q3 FY2018 | Sep 30, 2018 | $7.51B | +5.5% |
| Q2 FY2018 | Jun 30, 2018 | $7.34B | +4.1% |
| Q1 FY2018 | Mar 31, 2018 | $7.48B | +19.1% |
| Q4 FY2017 | Dec 31, 2017 | $7.29B | +20.3% |
| Q3 FY2017 | Sep 30, 2017 | $7.12B | – |
| Q2 FY2017 | Jun 30, 2017 | $7.05B | – |
| Q1 FY2017 | Mar 31, 2017 | $6.28B | – |
| Q4 FY2016 | Dec 31, 2016 | $6.06B | – |
See a number that looks wrong?